Notice of Special Interest: Availability of Emergency Competitive Revisions and Administrative Supplements to address COVID-19 Public Health Needs
The North Carolina Translational and Clinical Sciences (NC TraCS) Institute wants you to be aware of a Notice of Special Interest (NOSI): "Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs”.
There are two announcements related to this notice.
- PA-20-135 – “Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)”
- PA-18-591 – “Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)”
The stated purpose of the NOSI: “The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. NCATS is soliciting applications for Administrative Supplements (through PA-18-591) and Emergency Competitive Revisions (through PA-20-135) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients.”
